Peter V. Sguigna

466 total citations
22 papers, 340 citations indexed

About

Peter V. Sguigna is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Peter V. Sguigna has authored 22 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Peter V. Sguigna's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Systemic Lupus Erythematosus Research (4 papers). Peter V. Sguigna is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Systemic Lupus Erythematosus Research (4 papers). Peter V. Sguigna collaborates with scholars based in United States and Germany. Peter V. Sguigna's co-authors include Russell A. DeBose‐Boyd, Youngah Jo, Peter Chang-Whan Lee, Benjamin Greenberg, Cynthia Wang, Khalil S. Husari, Ram Narayan, Darrel Conger, Olaf Stüve and Jimin Ren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Peter V. Sguigna

17 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter V. Sguigna United States 7 150 93 89 65 56 22 340
Daria A. Chudakova Russia 11 294 2.0× 63 0.7× 55 0.6× 41 0.6× 28 0.5× 28 437
A. Rocchini United States 5 184 1.2× 47 0.5× 24 0.3× 70 1.1× 44 0.8× 5 431
Xian Qiao China 9 143 1.0× 45 0.5× 31 0.3× 14 0.2× 83 1.5× 19 348
Heidi Högel Finland 10 194 1.3× 26 0.3× 24 0.3× 123 1.9× 53 0.9× 12 363
Yasuya Inomata Japan 17 373 2.5× 75 0.8× 20 0.2× 24 0.4× 64 1.1× 27 822
Laura González Spain 13 313 2.1× 48 0.5× 31 0.3× 11 0.2× 26 0.5× 23 441
Cinzia Bragato Italy 14 326 2.2× 88 0.9× 36 0.4× 8 0.1× 89 1.6× 26 507
Fatemeh Sharifpanah Germany 12 198 1.3× 33 0.4× 67 0.8× 25 0.4× 12 0.2× 27 348
Takahisa Koga Japan 16 301 2.0× 145 1.6× 20 0.2× 23 0.4× 25 0.4× 24 651
Lauren Brady Canada 17 360 2.4× 57 0.6× 26 0.3× 23 0.4× 72 1.3× 40 558

Countries citing papers authored by Peter V. Sguigna

Since Specialization
Citations

This map shows the geographic impact of Peter V. Sguigna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Sguigna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Sguigna more than expected).

Fields of papers citing papers by Peter V. Sguigna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Sguigna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Sguigna. The network helps show where Peter V. Sguigna may publish in the future.

Co-authorship network of co-authors of Peter V. Sguigna

This figure shows the co-authorship network connecting the top 25 collaborators of Peter V. Sguigna. A scholar is included among the top collaborators of Peter V. Sguigna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter V. Sguigna. Peter V. Sguigna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenyang, Peter V. Sguigna, Hisham Salahuddin, et al.. (2025). Detection of Varicella Zoster Virus Reactivation in Cerebrospinal Fluid in Ischemic Stroke or Transient Ischemic Attack. Journal of the American Heart Association. 14(13). e039489–e039489.
2.
Shang, Ty, Peter V. Sguigna, Marco C. Pinho, et al.. (2025). Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy. Neurology. 104(2). e210258–e210258. 3 indexed citations
3.
Sguigna, Peter V., Rehana Z. Hussain, Kyle Blackburn, et al.. (2024). Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design. Therapeutic Advances in Neurological Disorders. 17. 3 indexed citations
4.
Blackburn, Kyle, et al.. (2024). Design and Implementation of a Brief, Self-Directed Course on Immunotherapy Best Practices for Neurology Trainees. SHILAP Revista de lepidopterología. 11. 2357662970–2357662970.
5.
Villalobos, Francisco J., Kevin Shan, Peter V. Sguigna, et al.. (2024). Generative artificial intelligence versus clinicians: Who diagnoses multiple sclerosis faster and with greater accuracy?. Multiple Sclerosis and Related Disorders. 90. 105791–105791. 6 indexed citations
6.
Shan, Kevin, Morgan McCreary, Francisco J. Villalobos, et al.. (2024). Faster and better than a physician?: Assessing diagnostic proficiency of ChatGPT in misdiagnosed individuals with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences. 468. 123360–123360. 1 indexed citations
7.
Sguigna, Peter V., Kyle Blackburn, Darrel Conger, et al.. (2023). Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(1). 3100522760–3100522760. 1 indexed citations
8.
Salter, Amber, et al.. (2023). A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis. Therapeutic Advances in Chronic Disease. 14. 384251221–384251221.
9.
Nguyen, Linda, et al.. (2023). Subclinical optic neuritis in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple Sclerosis and Related Disorders. 76. 104802–104802. 4 indexed citations
10.
11.
Sguigna, Peter V., Kyle Blackburn, Darrel Conger, et al.. (2022). Application of the International Interocular Difference Thresholds into Practice: Localising the Patient Experience. Neuro-Ophthalmology. 46(6). 375–382. 1 indexed citations
12.
Goodspeed, Kimberly, et al.. (2022). A cross‐sectional natural history study of aspartylglucosaminuria. JIMD Reports. 63(5). 425–433. 2 indexed citations
13.
Sguigna, Peter V., Morgan McCreary, Darrel Conger, et al.. (2020). Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population. Journal of Neuro-Ophthalmology. 41(1). 19–23. 4 indexed citations
14.
Sguigna, Peter V., et al.. (2018). Aseptic Meningitis as a Manifestation of the Anti-MOG Syndrome (P5.422). Neurology. 90(15_supplement). 1 indexed citations
15.
Narayan, Ram, Cynthia Wang, Peter V. Sguigna, Khalil S. Husari, & Benjamin Greenberg. (2018). Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Multiple Sclerosis and Related Disorders. 27. 30–33. 46 indexed citations
16.
Sguigna, Peter V., Shin C. Beh, Eric Kildebeck, et al.. (2017). Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics. JAMA Neurology. 74(5). 574–574. 24 indexed citations
17.
Hussain, Rehana Z., Peter V. Sguigna, Ellen Marder, et al.. (2016). Acute relapse after initiation of Siponimod in a patient with secondary progressive MS. Journal of Neurology. 263(3). 606–610. 4 indexed citations
18.
Dubey, Divyanshu, Peter V. Sguigna, & Olaf Stüve. (2016). Managing Disability in Progressive Multiple Sclerosis. Current Treatment Options in Neurology. 18(6). 27–27. 7 indexed citations
19.
Jo, Youngah, Peter V. Sguigna, & Russell A. DeBose‐Boyd. (2011). Membrane-associated Ubiquitin Ligase Complex Containing gp78 Mediates Sterol-accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase. Journal of Biological Chemistry. 286(17). 15022–15031. 77 indexed citations
20.
Jo, Youngah, Peter Chang-Whan Lee, Peter V. Sguigna, & Russell A. DeBose‐Boyd. (2011). Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8. Proceedings of the National Academy of Sciences. 108(51). 20503–20508. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daria A. Chudakova Breakdown of academic impact, for papers by A. Rocchini Breakdown of academic impact, for papers by Xian Qiao Breakdown of academic impact, for papers by Heidi Högel Breakdown of academic impact, for papers by Yasuya Inomata Breakdown of academic impact, for papers by Laura González Breakdown of academic impact, for papers by Cinzia Bragato Breakdown of academic impact, for papers by Fatemeh Sharifpanah Breakdown of academic impact, for papers by Takahisa Koga Breakdown of academic impact, for papers by Lauren Brady
Rankless by CCL
2026